🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with blood pressure reduction mechanisms on glp-1? Page 8

Has anyone dealt with blood pressure reduction mechanisms on glp-1?

ZaraB_AL Mon, Jul 22, 2024 at 12:53 PM 53 replies 2,492 viewsPage 8 of 11
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Aug 17, 2024 at 12:27 PM#36
VendorMark said:
6 month update on cardiovascular risk: down 47 lbs, off blood pressure meds, A1C normalized.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.

36 9julia.endo, JessicaM_2024, TomFromTexas and 33 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Aug 18, 2024 at 8:10 PM#37

Adding the clinical framing, because it changes how the question reads.

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 50 pg/mL (normal, cardiac function preserved)
  • Lp(a): 60 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 145 to 90 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

Last edited: Aug 19, 2024 at 2:10 AM
37 10roxy_nash, tony_orlando, Dr.NephBHM_UK and 34 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Aug 20, 2024 at 3:52 AM#38
roxy_nash said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

38 11PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 35 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Aug 21, 2024 at 11:33 AM#39
roxy_nash said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.
roxy_nash said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

Last edited: Aug 21, 2024 at 4:33 PM
39 12MikeFit_NJ, InsuranceTom, WendyG_ATL and 36 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Aug 22, 2024 at 7:13 PM#40

Adding the numbers, since they settle part of this. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

11 9Dr.DermMIA, fiona_VT, denise_HTX and 8 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register